|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Bioverativ
gptkb:2011
gptkb:2018
gptkb:2020
gptkb:Genzyme_Corporation
gptkb:Principia_Biopharma
|
|
gptkbp:awards
|
recognized for innovation
received multiple industry awards
|
|
gptkbp:ceo
|
gptkb:Paul_Hudson
|
|
gptkbp:clinical_trial
|
conducts numerous clinical trials
|
|
gptkbp:community_engagement
|
participates in health awareness campaigns
supports patient advocacy groups
engages in community support programs
|
|
gptkbp:employees
|
over 10,000
|
|
gptkbp:focus_area
|
gptkb:psychologist
neurology
oncology
rare diseases
|
|
gptkbp:founded
|
gptkb:1981
|
|
gptkbp:global_presence
|
operates in over 40 countries
|
|
gptkbp:headquarters
|
gptkb:Cambridge,_Massachusetts
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Sanofi Genzyme
|
|
gptkbp:mission
|
develop innovative therapies
improve the lives of patients with rare diseases
|
|
gptkbp:parent_company
|
gptkb:Sanofi
|
|
gptkbp:partnership
|
collaborates with academic institutions
collaborates with healthcare organizations
|
|
gptkbp:products
|
gptkb:Dupixent
gptkb:Aubagio
gptkb:Cerezyme
gptkb:Fabrazyme
gptkb:Lemtrada
gptkb:Myozyme
gptkb:Synvisc
|
|
gptkbp:research_and_development
|
invests heavily in R& D
|
|
gptkbp:research_areas
|
gptkb:Company
hematology
infectious diseases
immunology
cardiovascular
|
|
gptkbp:subsidiary
|
gptkb:Genzyme_Genetics
gptkb:Genzyme_Biosurgery
gptkb:Genzyme_Pharmaceuticals
gptkb:Genzyme_Sanofi
gptkb:Genzyme_Therapeutics
|
|
gptkbp:sustainability_initiatives
|
reducing environmental impact
committed to sustainability
promoting access to medicines
|
|
gptkbp:website
|
www.sanofi.com
|
|
gptkbp:bfsParent
|
gptkb:Sanofi
|
|
gptkbp:bfsLayer
|
3
|